![Kirsten Drejer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirsten Drejer
Presidente presso
CURASIGHT A/S
Patrimonio netto: 561 529 $ in data 30/06/2026
Profilo
Kirsten Aarup Drejer was the founder of Servier Symphogen A, founded in 2000, and served as Chief Executive Officer from 2000 to 2016.
Current jobs include Vice Chairman at Zealand Pharma A since 2019, Chairman at Curasight A since 2024, Chairman at Bioneer A since 2017, Chairman at ResoTher Pharma AS since 2018, and Director at Lyhne & Co. Former jobs include Director at International N&H Denmark ApS from 2006 to 2011, Independent Director at Bioporto A from 2017 to 2021, Independent Director at Alligator Bioscience AB from 2019 to 2021, Director at DTU Systems Biology, Independent Non-Executive Director at Bionor Pharma ASA from 2015 to 2016, Director at The Danish Green Growth Fund, Independent Non-Executive Director at Malin Corp.
Plc from 2020 to 2026, Director-Diabetes Discovery at Novo Nordisk A from 1992 to 2000, Director at The Danish National Advanced Technology Foundation from 2010 to 2012, Director at Antag Therapeutics ApS, and Professor at the University of Copenhagen.
Education includes graduate and doctorate degrees from Danmarks Farmaceutiske Universitet.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,02% | 31/12/2025 | 12.177 ( 0,02% ) | 539 379 $ | 30/06/2026 |
CURASIGHT A/S 0,01% | 30/06/2025 | 6.929 ( 0,01% ) | 22 150 $ | 30/06/2026 |
Posizioni attive di Kirsten Drejer
| Società | Posizione | Inizio |
|---|---|---|
| ZEALAND PHARMA A/S | Direttore/Membro del Consiglio | 19/04/2018 |
| CURASIGHT A/S | Presidente | 01/01/2024 |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Presidente | 01/04/2017 |
Lyhne & Co. | Direttore/Membro del Consiglio | - |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Presidente | 10/07/2018 |
Precedenti posizioni note di Kirsten Drejer
| Società | Posizione | Fine |
|---|---|---|
| MALIN CORPORATION PLC | Direttore/Membro del Consiglio | 26/03/2026 |
The Danish Green Growth Fund
 The Danish Green Growth Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direttore/Membro del Consiglio | 02/01/2023 |
| ALLIGATOR BIOSCIENCE AB | Direttore/Membro del Consiglio | 01/06/2021 |
| BIOPORTO A/S | Direttore/Membro del Consiglio | 29/04/2021 |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Kirsten Drejer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Malin Corp. Plc
 Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables Produces food enzymes, products and pharmaceutical grade excipients for food products | Consumer Non-Durables |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danmarks Farmaceutiske Universitet
 Danmarks Farmaceutiske Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
DTU Systems Biology | |
The Danish National Advanced Technology Foundation
 The Danish National Advanced Technology Foundation Financial ConglomeratesFinance Promotes research and innovation by providing funds | Finance |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Curasight A/S
 Curasight A/S Medical SpecialtiesHealth Technology Provides PET imaging research techniques for prostate cancer | Health Technology |
The Danish Green Growth Fund
The Danish Green Growth Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Antag Therapeutics ApS
 Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services | Health Services |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Health Technology |
Lyhne & Co. |
